Rep. Gilbert Ray Cisneros Jr. (D-CA) Sells Revvity (RVTY) Stock

Rep. Gilbert Ray Cisneros Jr., a Democrat serving in the House from California's 31st district, sold shares of Revvity, Inc. (RVTY) on September 3, 2026. This trade is valued between $1,001 and $15,000. The sale was reported on October 12, 2026.

Inside Gilbert Ray Cisneros Jr.'s Trade

Cisneros's transaction reflects a personal decision to sell shares in Revvity, a company known for its healthcare solutions and technologies. The reported value of the trade suggests that it falls within a mid-range of approximately $8,000.

Other Institutional Activity in Revvity, Inc.

T. Rowe Price Investment Management, Inc. cut its stake by 3,938,163 shares, ending up with 18,261,177 shares worth about $2.79 billion. Jupiter Topco LLC increased its holdings by 4,318,807 shares, bringing its total to 8,637,614 shares valued at around $1.32 billion. Edgepoint Investment Group Inc. pared its position, selling 256,097 shares to hold a total of 8,544,479 shares worth about $1.30 billion. BlackRock Inc. added 408,185 shares, ending with 7,658,369 shares valued at around $1.17 billion, while Vanguard Capital Management LLC decreased its holdings slightly by 29,321 shares, ending with 7,300,973 shares worth about $1.11 billion.

Revvity, Inc. Stock Up 6.9%

Revvity, Inc. shares closed at $153.35 on the day of publication, which is strong, especially considering the stock's proximity to its 52-week high of $149.52. The stock has performed well, showing resilience as it trades significantly above its 200-day moving average of $104.10.

Recent Earnings

In its latest earnings report for the year ended December 31, 2025, Revvity generated revenue of approximately $2.91 billion, with a net margin of about 8.16%. The company's earnings per share (EPS) stood at $2.08. Investors are looking ahead to the next earnings date on October 26, 2026.

Dividend

Revvity, Inc. pays an annual dividend rate of $0.28 per share, which translates to a yield of about 0.20%. The company maintains a healthy dividend payout ratio of 13.46%.

Insider Buying and Selling at Revvity, Inc.

Several insiders at Revvity have also been active. Chief Financial Officer Krakowiak Maxwell sold 1,631 shares at an average price of $144.53 on September 21, 2026, totaling about $235,728. Officer Anita Gonzales sold 85 shares at $109.48 on July 20, 2026, worth around $9,306. Earlier in the year, Gonzales also sold 80 shares at $92.80, totaling about $7,424, while officer Victor Miriame sold 1,862 shares at $97.13 on February 24, 2026, valued at approximately $180,856.

Analysts Set New Price Targets

On October 13, 2026, TD Cowen maintained a Buy rating on Revvity with a price target of $175. Earlier, on October 7, Barclays maintained an Equal-Weight rating with a target of $160, raised from $115. KeyBanc also maintained an Overweight rating with a target of $165 as of September 4, 2026. The consensus rating for Revvity is a Buy, with an average target price of $128.47 from 17 analysts.

About Revvity, Inc.

Revvity, Inc. focuses on health sciences, offering various technologies and services aimed at early detection of medical conditions. The company provides a range of diagnostic tools and software to improve healthcare outcomes. This recent trade by Cisneros reflects ongoing interest in the diagnostics sector, which is crucial for timely medical interventions.

Bottom Line

As Revvity prepares for its next earnings report on October 26, investors will be watching any further trades by insiders, like Cisneros, for insights into market sentiment. The trade reported here is based on a Form 4 filed after the sale and may not reflect current holdings.